Emily Land

/ /

Ending Hepatitis C Means Including People Who Inject Drugs

With affordable, highly-effective hepatitis C (HCV) direct acting antiretroviral medications now available, innovative programs in San Francisco are reaching people who inject drugs with hepatitis C cure support and treatment. Clinicians and advocates who recognize the benefit of treating everyone with hepatitis C—regardless of their substance use—are advocating for a non-judgmental approach to this deadly infection. Pierre-Cédric Crouch, PhD, ANP-BC “We recently expanded our hepatitis C treatment program to the 6th Street Harm Reduction Center, which primarily serve people who are homeless or marginally housed, and who use substances including injection drugs,” said Pierre-Cedric Crouch, PhD, ANP-BC, nursing director of […]

/ /

Status check: PrEP Uptake & Delivery

In the U.S., the CDC estimates that more than one million people (1,232,000) are at sufficient risk for HIV to meet PrEP prescribing guidelines. This stands in stark contrast to the most recent estimate of approximately 120,000 people currently taking PrEP (based on pharmacy data) by the first quarter of 2017. How are public health and community health organizations creating demand and facilitating access to PrEP—and what more can be done? Kenneth Mayer, MD, medical research director and co-chair of The Fenway Institute, joined BETA to answer questions about the opportunities to expand PrEP access in the U.S., and explain […]

1 2